ClinicalTrials.govpublic full text
PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors
breast neoplasms, her2, pf-06804103, adc, breast cancer, neoplasms, solid tumors, human epidermal growth receptor 2, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895346
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.